New MRI Technology approved by the FDA --

"Traditional MRIs offer only one level of contrast when depicting tissue. SyMRI NEURO is the first to offer several levels, giving doctors more information about tissue properties.

This feature can help doctors who are studying multiple sclerosis patients’ brain scans get a better handle on damage to the myelin sheath that protects nerve cells. Deterioration of the sheath is a hallmark of MS."

https://multiplesclerosisnewstoday.com/2018/01/30/fda-approves-syntheticmr-technology-that-provides-more-information-about-ms-from-mri-scans/?utm_source=Multiple+Sclerosis&utm_campaign=482f047813-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-482f047813-71788225

Read about the FDA approving the Swedish company SyntheticMR's MRI-enhancing technology. It offers doctors more information to diagnose and treat MS.